FindTrial
Sign In

Clinicopathological characteristics and survival outcomes in acinar cell carcinoma of pancreas: a population-based, cohort study from the surveillance, epidemiology and end results (SEER) database

Clinicopathological characteristics and survival outcomes in acinar cell carcinoma of pancreas: a population-based, cohort study from the surveillance, epidemiology and end results (SEER) database

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020079
Enrollment
Unknown
Registered
2018-12-13
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic ductal adenocarcinoma and pancreatic acinar cell carcinoma

Interventions

Case series:No intervention.

Sponsors

Zhongshan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 103 Years

Inclusion criteria

Inclusion criteria: These are criteria of how we enrolled patients from surveillance, epidemiology, and end results (SEER) database: 1. Site recode ICD-O-3/WHO 2008: Pancreas; 2. Histologic Type ICD-O-3: 8550, 8551, 8140, 8141, 8144, and 8145; 3. Year of diagnosis: 2004-2014; 4. Cancer death and follow up: Active follow-up; 5. Survival months flag: Complete dates are available and there are more than 0 days of survival; 6. Diagnostic confirmation: Microscopically confirmed, positive histology, positive exfoliative cytology but no positive histology, Pos hist AND immunophenotyping AND/OR pos genetic mutataion; 7. First malignant primary indicator: Yes.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Countries

China

Contacts

Public ContactWenhui Lou

Zhongshan Hospital Fudan University

xu0816@126.com+86 18817583729

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026